Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Director departure
MALACHITE INNOVATIONS, INC. (VBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 8-K Quarterly results
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/31/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MALACHITE INNOVATIONS REPORTS FIRST QUARTER 2023 RESULTS"
04/13/2023 8-K Quarterly results
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/31/2023 5 Celeste Richard F (Director) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
03/31/2023 5 Cavanaugh Michael R. (CEO) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
03/31/2023 5 Zipp Brandon Joel (Chief Science Officer) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
03/31/2023 5 MCKILLIGAN RICHARD (CFO) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
03/31/2023 5 FEIGHAN EDWARD F (Director) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
09/22/2022 8-K/A Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Independent Registered Public Accounting Firm",
"Financial Statements Page Independent Auditor’ s Report F-2 Balance Sheets as of December 31, 2021 and December 31, 2020 F-3 Statements of Operations for the years ended December 31, 2021 and December 31, 2020 F-4 Statements of Stockholders’ Equity for the years ended December 31, 2021 and December 31, 2020 F-5 Statements of Cash Flows for the years ended December 31, 2021 and December 31, 2020 F-6 Notes to Financial Statements F-7 F- 1 Independent Auditor’ s Report To the Shareholders of Range Environmental Resources, Inc.",
"Malachite Innovations, Inc. Pro Forma Consolidated Balance Sheet Malachite Innovations Inc. Range Environmental Resources, Inc. Pro Forma Adjustments Pro Forma Total Current assets Cash $ 44,162 $ 87,058 $ - $ 131,220 Accounts receivable, net - 853,311 - 853,311 Prepaid expenses 884 - - 884 Total current assets 45,046 940,369 - 985,415 Property and equipment, net of accumulated depreciation - 400,886 182,114 583,000 Deposits 8,892 - - 8,892 Operating lease asset - 130,630 - 130,630 Goodwill - - 779,165 779,165 Total Assets 53,938 1,471,885 961,279 2,487,102 Current liabilities Accounts payable and accrued liabilities 133,553 286,998 - 420,551 Current portion of long-term debt - 49,625 - 49,625 Line of Credit 750,000 - - 750,000 Total current liabilities 883,553 336,623 - 1,220,176 Long-ter..."
08/29/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "FORM OF WARRANT NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED , AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. COMMON STOCK..."
08/16/2022 8-K Quarterly results
08/16/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
07/15/2022 8-K Quarterly results
06/01/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/27/2022 SC 13D/A LoConti Joseph E. reports a 37.4% stake in Malachite Innovations, Inc.
05/13/2022 8-K Quarterly results
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
03/31/2022 10-KT Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
03/15/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MALACHITE INNOVATIONS ANNOUNCES SIGNED LETTER OF INTENT WITH RANGE ENVIRONMENTAL RESOURCES, INC. 15 MAR 2022 / PRESS RELEASE",
"LETTER OF INTENT"
03/09/2022 8-K Quarterly results
12/28/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MALACHITE INNOVATIONS ANNOUNCES TWO GRANTED U.S. PATENTS AND NEW PCT PATENT FILING CLEVELAND, OHIO – – MALACHITE INNOVATIONS, INC. announces that its wholly-owned drug development subsidiary, Graphium Biosciences, Inc., has been granted two patents by the U.S. Patent and Trademark Office for its cannabinoid glycoside prodrug, and has filed a new patent under the Patent Cooperation Treaty for its novel manufacturing process used to produce its proprietary cannabinoid glycosides. The Company's new patent application was filed with the USPTO and preserves our right to seek patent protection in 153 foreign nations that are signatories of the PCT. Granted: Cannabinoid Glycoside Prodrugs and Methods of Synthesis Graphium Biosciences has been granted a patent by the USPTO for its “Cannabinoid Gly..."
11/15/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/12/2021 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...
Docs: "PLAN OF MERGER THIS PLAN OF MERGER is adopted, made and entered into as of September 30, 2021 by Vitality Biopharma, Inc., a Nevada corporation , in accordance with Section 92A.180 of the Nevada Revised Statutes . 1. Parent and Subsidiary . Malachite Innovations, Inc., a Nevada corporation , is a wholly-owned subsidiary of Parent. 2. Merger . Merger Sub shall be merged with and into Parent at the Effective Time . Following the Effective Time, the separate existence of Merger Sub shall cease, and Parent shall continue as the surviving corporation surviving the Merger and its name shall be changed to “Malachite Innovations, Inc.” . The effects and consequences of the Merger shall be as set forth in this Plan of Merger, the Articles of Merger filed with the Secretary of State of the State of ...",
"VITALITY BIOPHARMA ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC."
09/03/2021 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
09/02/2021 8-K Quarterly results
09/02/2021 424B1 Form 424B1 - Prospectus [Rule 424(b)(1)]:
09/02/2021 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
08/23/2021 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/20/2021 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "VITALITY BIOPHARMA ENTERS INTO $5 MILLION EQUITY LINE FINANCING RELATIONSHIP WITH INSTITUTIONAL INVESTOR"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy